HIV Prevention With Positives: Often Ignored, Yet Often Effective

Winter 2011

 < Prev  |  1  |  2  |  3  |  4 

HIV Clinician/Researchers Who Offered RITA! Opinions on Primary Prevention

John A. Bartlett, MD
Duke University Medical Center
Durham, North Carolina

Cal Cohen, MD
Community Research Initiative
Boston, Massachusetts

Ann C. Collier, MD
University of Washington
Seattle, Washington

Eric S. Daar, MD
David Geffen School of Medicine at UCLA
Los Angeles, California

Steven G. Deeks, MD
University of California
San Francisco, California

Carl J. Fichtenbaum, MD
University of Cincinnati College of Medicine
Cincinnati, Ohio

Ian Frank, MD
University of Pennsylvania
Philadelphia, Pennsylvania

Joel Gallant, MD, MPH
Johns Hopkins University
Baltimore, Maryland

Marshall J. Glesby, MD, PhD
Weill Cornell Medical College
New York, New York

Richard H. Haubrich, MD
University of California
San Diego, California

Charles B. Hicks, MD
Duke School of Medicine
Durham, North Carolina

David A. Katzenstein, MD
Stanford School of Medicine
Stanford, California

David M. Margolis, MD
University of North Carolina
Chapel Hill, North Carolina

Paul E. Sax, MD
Harvard Medical Schoolv Boston, Massachusetts

Jonathan Schapiro, MD
Sheba Medical Center
Tel Hashomer Ramat Gan, Israel

Susan Swindells, MBBS
University of Nebraska Medical Center
Omaha, Nebraska

Babafemi Taiwo, MBBS
Northwestern University
Feinberg School of Medicine Chicago, Illinois

David A. Wohl, MD
University of North Carolina
Chapel Hill, North Carolina


  1. Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV: recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR. 2003;52(No. RR-12). Accessed October 8, 2011.
  2. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505. Accessed October 10, 2011.
  3. US Department of Health and Human Services Health Resources and Services Administration. Guide for HIV/AIDS Clinical Care. January 2011. Accessed October 10, 2011.
  4. Marks G, Richardson JL, Crepaz N, et al. Are HIV care providers talking with patients about safer sex and disclosure? A multi-clinic assessment. AIDS. 2002;16:1953-1957.
  5. Steward WT, Charlebois ED, Johnson MO, Remien RH, Goldstein RB, Wong FL, Morin SF. Receipt of prevention services among HIV-infected men who have sex with men. Am J Public Health. 2008;98:1011-1014.
  6. Steward WT, Koester KA, Myers JJ, Morin SF. Provider fatalism reduces the likelihood of HIV prevention counseling in primary care settings. AIDS Behav. 2006;10:3-12.
  7. Gardner LI, Metsch L, Strathdee SA, del Rio C, Mahoney P, Holmberg SD. Frequency of discussing HIV prevention and care topics with patients with HIV: influence of physician gender, race/ethnicity, and practice characteristics. Gend Med. 2008;5:259-269.
  8. Morin SF, Koester KA, Steward WT, et al. Missed opportunities: prevention with HIV-infected patients in clinical care settings. J Acquir Immune Defic Syndr. 2004;36:960-966.
  9. Richardson JL, Milam J, McCutchan A, et al. Effect of brief safer-sex counseling by medical providers to HIV-1 seropositive patients: a multi-clinic assessment. AIDS. 2004;18:1179-1186.
  10. Myers JJ, Shade SB, Rose CD, et al. Interventions delivered in clinical settings are effective in reducing risk of HIV transmission among people living with HIV: results from the Health Resources and Services Administration (HRSA)'s Special Projects of National Significance initiative. AIDS Behav. 2010;14:483-492.
  11. Marseille E, Shade SB, Myers J, Morin S. The cost-effectiveness of HIV prevention interventions for HIV-infected patients seen in clinical settings. J Acquir Immune Defic Syndr. 2011;56:e87-e94.
  12. Myers JJ, Steward WT, Charlebois E, Koester KA, Maiorana A, Morin SF. Written clinic procedures enhance delivery of HIV "prevention with positives" counseling in primary health care settings. J Acquir Immune Defic Syndr. 2004;37(suppl 2):S95-S100.
  13. Lightfoot M, Rotheram-Borus MJ, Comulada WS, Reddy VS, Duan N. Efficacy of brief interventions in clinical care settings for persons living with HIV. J Acquir Immune Defic Syndr. 2010;53:348-356.
  14. Gilbert P, Ciccarone D, Gansky SA, et al. Interactive "video doctor" counseling reduces drug and sexual risk behaviors among HIV-positive patients in diverse outpatient settings. PLoS One. 2008;3(4):e1988. Accessed November 11, 2011.
  15. Woloshin S, Schwartz LM, Welch HG. The risk of death by age, sex, and smoking status in the United States: putting health risks in context. J Natl Cancer Inst. 2008;100:845-853.
  16. American Pregnancy Association. Miscarriage. Accessed October 14, 2011.
  17. Hall HI, An Q, Hutchinson AB, Sansom S. Estimating the lifetime risk of a diagnosis of the HIV infection in 33 states, 2004-2005. J Acquir Immune Defic Syndr. 2008;49:294-297.
  18. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med. 2000;342:921-929. Accessed October 20, 2011.
  19. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis. 2005;191:1403-1409.
  20. Jin F, Jansson J, Law M, et al. Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS. 2010;24:907-913.
  21. CDC HIV/AIDS Facts. HIV transmission rates in the United States. December 2008. Accessed October 14, 2011.
  22. Holtgrave D, Hall HI, Rhodes PH, Wolitski R. Updated annual HIV transmission rates in the United States, 1977-2006. J Acquir Immune Defic Syndr. 2009;50:236-238. Search for Holtgrave and click on title. Accessed October 14, 2011.
  23. Centers for Disease Control and Prevention. HIV Surveillance -- United States, 1981-2008. MMWR. 2011;60(21):689-693. Accessed November 10, 2011.
  24. Prejean J, Song R, Hernandez A, et al. Estimated HIV incidence in the United States, 2006-2009. PLoS One. 2011;6(8):e17502.
  25. Porco TC, Martin JN, Page-Shafer KA, et al. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS. 2004;18:81-88.
  26. Montaner JS, Lima VD, Barrios R, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet. 2010;376:532-539.
  27. Das M, Chu PL, Santos GM, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One. 2010;5(6):e11068.
  28. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;26;10:1447-1450.
  29. Mascolini M. Late HIV diagnosis: predictors, costs, consequences, and solutions. RITA!. Accessed October 19, 2011.
  30. SJ Clark, MS Saag, WD Decker, et al. High titers of cytopathic virus in plasma of patients with symptomatic HIV-1 infection. N Engl J Med. 1991;324:954-960.
  31. Pilcher CD, Tien HS, Eron JJ. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis. 2004;189:1785-1792.
  32. Brenner BG, Roger M, Routy JP et al. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis. 2007;195:951-959.
  33. Remien RH, Higgins JA, Correale J, et al. Lack of understanding of acute HIV infection among newly-infected persons-implications for prevention and public health: the NIMH Multisite Acute HIV Infection Study: II. AIDS Behav. 2009;13:1046-1053.
  34. Morin SF, Myers JJ, Shade SB, Koester K, Maiorana A, Rose CD. Predicting HIV transmission risk among HIV-infected patients seen in clinical settings. AIDS Behav. 2007;11(suppl 5):S6-S16.
  35. Weinhardt LS, Kelly JA, Brondino MJ, et al; National Institute of Mental Health Healthy Living Project Team. HIV transmission risk behavior among men and women living with HIV in 4 cities in the United States. J Acquir Immune Defic Syndr. 2004;36:1057-1066.
  36. Sullivan PS, Salazar L, Buchbinder S, Sanchez TH. Estimating the proportion of HIV transmissions from main sex partners among men who have sex with men in five US cities. AIDS. 2009;23:1153-1162.
  37. Morin S, Steward WT, Charlebois ED, et al. Predicting HIV transmission risk among HIV-infected men who have sex with men: findings from the Healthy Living Project. J Acquir Immune Defic Syndr. 2005;40:226-235.
  38. Semple SJ, Patterson TL, Grant I. Binge use of methamphetamine among HIV-positive men who have sex with men: pilot data and HIV prevention implications. AIDS Educ Prev. 2003;15:133-147.
  39. Harzke AJ, Williams ML, Bowen AM. Binge use of crack cocaine and sexual risk behaviors among African-American, HIV-positive users. AIDS Behav. 2009;13:1106-1118.
  40. Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357:1397-1401.
  41. CDC. Drug-associated HIV transmission continues in the United States. May 2002. Last modified March 8, 2007. Accessed October 20, 2011.
  42. Comulada WS, Rotheram-Borus MJ, Pequegnat W, et al. Relationships over time between mental health symptoms and transmission risk among persons living with HIV. Psychol Addict Behav. 2010;24:109-118. Accessed October 20, 2011.
  43. Wilson TE, Barron Y, Cohen M, et al. The Women's Interagency HIV Study. Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin Infect Dis. 2002;34:529-534.
  44. Shannon K, Kerr T, Milloy MJ, et al. Severe food insecurity is associated with elevated unprotected sex among HIV-seropositive injection drug users independent of HAART use. AIDS. 2011;25: 2037-2042.
 < Prev  |  1  |  2  |  3  |  4 

This article was provided by The Center for AIDS Information & Advocacy. It is a part of the publication Research Initiative/Treatment Action!. Visit CFA's website to find out more about their activities and publications.

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.